The impact of data extrapolation on publication planning for etanercept and rituximab biosimilars

被引：0

作者：

Reardon, Tony ^{[1
]}

Caldwell, Ben ^{[1
]}

机构：

[1] Spirit Med Commun Grp, Manchester, Lancs, England

来源：

CURRENT MEDICAL RESEARCH AND OPINION | 2019年 / 35卷

关键词：

Literature search; publication planning; pharmaceutical;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：38 / 38

页数：1

共 50 条

[1] The impact of data extrapolation on publication plans for biosimilars
Kramer, Holly
Reardon, Tony
Bolland, Fiona
CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 : S16 - S16
[2] The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab
Giuliani, Jacopo
Bonetti, Andrea
ANTICANCER RESEARCH, 2019, 39 (07) : 3971 - 3973
[3] Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?
Lee, Howard
AAPS JOURNAL, 2014, 16 (01): : 22 - 26
[4] Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?
Howard Lee
The AAPS Journal, 2014, 16 : 22 - 26
[5] Erratum to: Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?
Howard Lee
The AAPS Journal, 2015, 17 : 1520 - 1521
[6] Data extrapolation techniques for energy systems planning
Malik, SB
Satsangi, PS
ENERGY CONVERSION AND MANAGEMENT, 1997, 38 (14) : 1459 - 1474
[7] BUDGET IMPACT OF ETANERCEPT BIOSIMILARS IN THE TREATMENT OF RHEUMATOID ARTHRISIS: AN ANALYSIS BASED ON FRENCH NATIONAL CLAIMS DATABASE
Trancart, M.
Lafuma, A.
Laurendeau, C.
VALUE IN HEALTH, 2016, 19 (07) : A532 - A533
[8] Identifying Researchers' Publication Strategies by Clustering Publication and Impact Data
Ayala-Bastidas, Gilberto
Ceballos, Hector G.
Garza, Sara E.
Cantu-Ortiz, Francisco J.
PUBLISHING RESEARCH QUARTERLY, 2021, 37 (03) : 347 - 363
[9] Identifying Researchers’ Publication Strategies by Clustering Publication and Impact Data
Gilberto Ayala-Bastidas
Hector G. Ceballos
Sara E. Garza
Francisco J. Cantu-Ortiz
Publishing Research Quarterly, 2021, 37 : 347 - 363
[10] Budget Impact Analysis of the Introduction of Rituximab and Trastuzumab Intravenous Biosimilars to EU-5 Markets
Minyoung Jang
Steven Simoens
Taeksang Kwon
BioDrugs, 2021, 35 : 89 - 101

← 1 2 3 4 5 →